Evidence map›Paper›PMID 18184802›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells.

Stina Feltenmark, Narinder Gautam, Asa Brunnström, William Griffiths, Linda Backman, Charlotte Edenius, Lennart Lindbom, Magnus Björkholm, Hans-Erik Claesson

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 178 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases.Clinical reviews in allergy & immunology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Stina FeltenmarkBiolipox AB, Berzelius Väg 3, SE-171 65 Solna, Sweden.
Narinder Gautam
Asa Brunnström
William Griffiths
Linda Backman
Charlotte Edenius
Lennart Lindbom
Magnus Björkholm
Hans-Erik Claesson
Karolinska Institutet · SEKarolinska University Hospital · SESwansea University · GB

Funding

Biotechnology and Biological Sciences Research Council BB/C511356/1Biotechnology and Biological Sciences Research Council BB/C515771/1
6 · The paper itself

Abstract

Human eosinophils contain abundant amounts of 15-lipoxygenase (LO)-1. The biological role of 15-LO-1 in humans, however, is unclear. Incubation of eosinophils with arachidonic acid led to formation of a product with a UV absorbance maximum at 282 nm and shorter retention time than leukotriene (LT)C4 in reverse-phase HPLC. Analysis with positive-ion electrospray tandem MS identified this eosinophil metabolite as 14,15-LTC4. This metabolite could be metabolized to 14,15-LTD4 and 14,15-LTE4 in eosinophils. Because eosinophils are such an abundant source of these metabolites and to avoid confusion with 5-LO-derived LTs, we suggest the names eoxin (EX)C4, -D4, and -E4 instead of 14,15-LTC4, -D4, and -E4, respectively. Cord blood-derived mast cells and surgically removed nasal polyps from allergic subjects also produced EXC4. Incubation of eosinophils with arachidonic acid favored the production of EXC4, whereas challenge with calcium ionophore led to exclusive formation of LTC4. Eosinophils produced EXC4 after challenge with the proinflammatory agents LTC4, prostaglandin D2, and IL-5, demonstrating that EXC4 can be synthesized from the endogenous pool of arachidonic acid. EXs induced increased permeability of endothelial cell monolayer in vitro, indicating that EXs can modulate and enhance vascular permeability, a hallmark of inflammation. In this model system, EXs were 100 times more potent than histamine and almost as potent as LTC4 and LTD4. Taken together, this article describes the formation of proinflammatory EXs, in particular in human eosinophils but also in human mast cells and nasal polyps.

Indexed as

Gene Expression Regulation, EnzymologicArachidonate 15-LipoxygenaseArachidonic AcidCalciumChromatography, LiquidEosinophilsHumansInterleukin-6Leukotriene C4Leukotriene E4LeukotrienesMass SpectrometryMast CellsModels, BiologicalModels, ChemicalProstaglandin D214-cysteinyl-15-hydroxy-5,8,10,12-eicosatetraenoic acidArachidonate 15-LipoxygenaseArachidonic AcidCalciumeoxin C4Interleukin-6Leukotriene C4Leukotriene E4LeukotrienesProstaglandin D2

Identifiers

PMID18184802
PMCPMC2206596
OpenAlexW2090060485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.